Dr. Tomic completed his medical education at the University of Zagreb in Croatia, followed with his residency at University of Illinois at Chicago, and fellowship at Emory University in Pulmonary and Critical Care Medicine. Dr. Tomic is double board-certified in Pulmonary Medicine and Critical Care Medicine and is most known for his research on interstitial lung disease and lung transplantation. His research interests include investigating photopheresis as a treatment for chronic rejection in lung transplant recipients. Dr. Tomic is well-published on the topics of lung transplantation and pulmonary fibrosis and other interstitial lung diseases, and is involved with several professional organizations, including the International Society for Heart and Lung Transplantation, American Thoracic Society and American College of Chest Physicians.
Double Lung Transplant as a Result of Post COVID-19 Fibrosis
Thursday, November 19, 2020, at 3:00pm
While the effect on those who have been infected with the COVID-19 has been varied, some patients have experienced devastating consequences. This predominantly respiratory virus has lead in some to pulmonary fibrosis, which has been so severe that Lung Transplantation has been the only option to allow patients the possibility of recovery. This Webinar will present an overview of COVID-19 and a case study of a patient who required lung transplantation for COVID-19 associated pulmonary fibrosis. The expert panel will discuss patient selection and evaluation, psychosocial implications of transplantation and the intense post-transplant care that the patient requires.